Home: For Medical Professionals
CTCL Masters Conference 2005

Below are links to the presentations from the 2005 CTCL Masters Conference.

Defining Patients and Prognosis
Moderator: Elise Olsen, MD

• Welcome and Introduction

• Diagnosis of CTCL (MF/SS)

• Prognosis and Goals of Therapy

• Skin Directed Therapy: TSEB and Total Body Nitrogen Mustard

• Skin Directed Therapy: Topical Chemo, Immunotherapy and UV Light

The Treatment of Refractory Patients
Moderator: Francine Foss, MD 

• Changing Paradigms: Immunotherapy vs Chemotherapy

• Step 1 Systemic Therapy With Targretin: Bexarotene Oral Capsules

• Step 1 Systemic Therapy With Targretin: PUVA-Bexarotene

• Step 2 Systemic Therapy: ONTAK

• Extracorporeal Photopheresis

• Investigational Chemotherapy and Other Agents

• Case History Discussion

• Panel Discussion

Management Issues and Panel Discussion
Moderator: Richard Ghalie, MD

• Medicare Legislative and Reimbursement Update

• Optimizing Therapy with Targretin

• Optimizing Therapy with Targretin - Anti-Lipid Use

• Optimizing Therapy with ONTAK

• Investigative Clinical Applications for ONTAK & Targretin